Imaging‐based diagnosis and classification of radioactive iodine‐induced sialadenitis
Authors:
- 10 December 2023
- journal article
- research article
- Published by Wiley in Oral Diseases
- Vol. 30 (7) , 4303-4311
Abstract
Objectives: To establish an inflammation grading system for radioactive iodine‐induced sialadenitis (RAIS) based on spiral computed tomography (CT), ultrasonography and sialography.Methods: In all, 120 RAIS patients (18 males and 102 females) were retrospectively included. Spiral CT, ultrasonography and sialography appearances were analysed and categorized as follows: grade I, approximately normal or mild sialadenitis; grade II, moderate sialadenitis; and grade III, severe sialadenitis. Adenitis severity was analysed relative to sex, age, RAI treatment sessions and cumulative doses.Results: Spiral CT showed heterogeneous (78.9%) and atrophic changes (36.8%) in the parotid glands (PGs) and duct ectasia (24.8%) in the submandibular glands (SMGs). Ultrasonography showed heterogeneous echogenicity (54.3%) and diminished gland size (30.2%) in PGs and duct ectasia in SMGs (34.7%). Sialography showed duct obliteration in 25.3% PGs and 3.2% SMGs. Statistical analysis showed good consistency among the three imaging grading results. The incidence and severity of PG lesions were significantly higher than that of SMGs (p < 0.001). As for PGs, adenitis severity was associated with both treatment sessions and cumulative doses; but in SMGs, disease severity was only related to treatment sessions.Conclusions: A grading system for severity of RAIS was established based on spiral CT, ultrasonography and sialography appearances.Keywords
Funding Information
- National Natural Science Foundation of China (81974151, 82270993)
This publication has 15 references indexed in Scilit:
- Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and RiskThyroid®, 2020
- Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinologyHead & Neck, 2020
- Does Salivary Function Decrease in Proportion to Radioiodine Dose?The Laryngoscope, 2019
- Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid CarcinomaThyroid®, 2017
- Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid CarcinomaUltrasound in Medicine & Biology, 2015
- Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-upNuclear Medicine Communications, 2015
- Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy doseClinical Imaging, 2015
- Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancerHead & Neck, 2010
- Salivary Gland Toxicity after Radioiodine Therapy for Thyroid CancerClinical Oncology, 2007
- Radioactive Iodine and the Salivary GlandsThyroid®, 2003